ATE79268T1 - Vorbeugende und therapeutische mittel fuer zerebrale ischaemie. - Google Patents

Vorbeugende und therapeutische mittel fuer zerebrale ischaemie.

Info

Publication number
ATE79268T1
ATE79268T1 AT87307383T AT87307383T ATE79268T1 AT E79268 T1 ATE79268 T1 AT E79268T1 AT 87307383 T AT87307383 T AT 87307383T AT 87307383 T AT87307383 T AT 87307383T AT E79268 T1 ATE79268 T1 AT E79268T1
Authority
AT
Austria
Prior art keywords
preventive
therapeutic means
cerebral ischaemia
alkyl group
prophylactic
Prior art date
Application number
AT87307383T
Other languages
English (en)
Inventor
Minoru Yamamoto
Nobuo Sakamoto
Yoshinobu Nagano
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Application granted granted Critical
Publication of ATE79268T1 publication Critical patent/ATE79268T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • A61K38/063Glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87307383T 1986-08-20 1987-08-20 Vorbeugende und therapeutische mittel fuer zerebrale ischaemie. ATE79268T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19600686 1986-08-20
EP87307383A EP0257992B1 (de) 1986-08-20 1987-08-20 Vorbeugende und therapeutische Mittel für zerebrale Ischämie

Publications (1)

Publication Number Publication Date
ATE79268T1 true ATE79268T1 (de) 1992-08-15

Family

ID=16350660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87307383T ATE79268T1 (de) 1986-08-20 1987-08-20 Vorbeugende und therapeutische mittel fuer zerebrale ischaemie.

Country Status (5)

Country Link
EP (1) EP0257992B1 (de)
JP (1) JPS63152325A (de)
KR (1) KR880002822A (de)
AT (1) ATE79268T1 (de)
DE (1) DE3781064T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968671A (en) * 1987-11-26 1990-11-06 Yamanouchi Pharmaceutical Co., Ltd. Therapeutic agents for ischemic heart diseases
US5093478A (en) * 1989-07-14 1992-03-03 Cornell Research Foundation, Inc. Preparing glutathione monoesters
DE69214467T3 (de) * 1991-01-10 2000-09-28 Transcend Therapeutics, Inc. Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5095027A (en) * 1991-02-28 1992-03-10 Clintec Nutrition Co. Method for treating reperfusion injury employing L-2-oxothiazolidine-4-carboxylic acid
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
WO1994025052A1 (en) * 1993-05-03 1994-11-10 Cornell Research Foundation, Inc. Use of glutathione diesters
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US20060105972A1 (en) 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58215188A (ja) * 1982-06-07 1983-12-14 Nippon Telegr & Teleph Corp <Ntt> メモ記入・表示回路
JPS60165883A (ja) * 1984-02-09 1985-08-29 Matsushita Electric Ind Co Ltd テレビジヨン信号送受信方法およびテレビジヨン信号受信方法
JPS61179691A (ja) * 1985-02-05 1986-08-12 Matsushita Graphic Commun Syst Inc 画像会議システム
JPH0783471B2 (ja) * 1985-06-13 1995-09-06 株式会社東芝 画像通信ネツトワ−ク装置

Also Published As

Publication number Publication date
EP0257992A3 (en) 1989-10-25
JPS63152325A (ja) 1988-06-24
KR880002822A (ko) 1988-05-11
EP0257992B1 (de) 1992-08-12
EP0257992A2 (de) 1988-03-02
DE3781064T2 (de) 1992-12-17
DE3781064D1 (de) 1992-09-17

Similar Documents

Publication Publication Date Title
NO303221B1 (no) Hydroksaminsyrederivater
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
DE3781064D1 (de) Vorbeugende und therapeutische mittel fuer zerebrale ischaemie.
IL88303A (en) Derivatives of 6-fluoro-7-û4-( (5-methyl-2-oxo-1,3- dioxolen-4-yl)methyl) piperazin-1-ylù-4 (1h)-oxo-1,3-thiazeto(3,2-a) quinoline-3-carboxylic acid
DE69921151D1 (de) Fluorszierende marker
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
DK0420121T3 (da) Antitumormiddel
DK0934939T3 (da) Neuraminsyreforbinelser
NO168421C (no) Analogifremgangsmaate ved fremstilling av antiarytmiske midler
ATE320417T1 (de) Naphthimidobenzamid-derivate
ATE274903T1 (de) Antivirale mittel
DE3862791D1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
EA200100967A1 (ru) Новое иммунодепрессивное средство
DK0420224T3 (da) Anthihepatopatisk middel
IE873442L (en) Cephalosporin derivative
DK0580378T3 (da) Substituerede benzoatderivater
DE69012845D1 (de) Exo-3&#39;-4&#39;-O-benzyliden-3&#34;-demethylchartreusin und seine Salze.
ATE141918T1 (de) Isoquinolinderivate
DK348389A (da) Phenylpropenderivater
ES2040223T3 (es) Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion.
EA200000300A1 (ru) Способ получения аминокарбонильных производных генезеролина, обладающих селективной в отношении головного мозга антихолинэстеразной активностью

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee